TRV-2026-1434Version 1 · Certified

Written 2026-10-15 10:42:03 UTC · current record

Reason for this version

Certified into the record

Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-1434
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-15T10:42:03.285097Z
status: published
lens: g_space
sector: health
headline: Artificial Intelligence for Cardiac Ischemia Detection: A Review of Biosensor, Biomarker, and Imaging Applications
dek: Ischemic heart disease is the leading cause of global mortality, yet accurate and timely detection remains constrained by incomplete signal capture, noise, operator dependence, and imperfect reference standards. Artificial intelligence (AI) may enhance cardiovascular sensing by extracting latent diagnostic information from routinely acquired signals. This narrative review examines AI-enabled approaches to ischemia detection across three sensing modalities: the electrocardiogram as a bioelectric sensor, cardiac t…
gain_title: AI can pull latent diagnostic information from routinely acquired cardiac signals, which could improve ischemia detection where noise, operator dependence and incomplete signal capture limit accuracy.
problem_title: (none)
trace_subject: (none)
gain_reading: AI can pull latent diagnostic information from routinely acquired cardiac signals, which could improve ischemia detection where noise, operator dependence and incomplete signal capture limit accuracy.
gain_evidence: Artificial intelligence (AI) may enhance cardiovascular sensing by extracting latent diagnostic information from routinely acquired signals.
problem_reading: (none)
problem_evidence: (none)
quick_read: This narrative review surveys how AI is being applied to detect cardiac ischemia through three kinds of sensing: the electrocardiogram as a bioelectric sensor, cardiac troponin as a biochemical marker, and imaging such as echocardiography, CT, MRI and nuclear imaging.

The review matters because ischemic heart disease is the leading cause of global mortality, so better and earlier detection could be consequential. The evidence is still thin, though: it rests mainly on retrospective diagnostic-performance studies, and benefits for workflow, patient outcomes and cost remain largely unmeasured.
limitation: Most evidence comes from retrospective, often single-center diagnostic-performance studies, with little evidence on workflow, patient outcomes or cost, so clinical benefit remains unproven.
tag: Evidence-backed gain
key_points: Ischemic heart disease is described as the leading cause of global mortality, and detection is limited by incomplete signal capture, noise, operator dependence and imperfect reference standards. | The review covers three modalities: ECG, cardiac troponin, and cardiac imaging including echocardiography, CT, MRI and nuclear imaging. | For each modality the authors assess the sensing pipeline, reference standards, the endpoint measured (from acute coronary occlusion to functional ischemia) and reported performance. | Emerging directions include foundation models and multimodal fusion. | Adoption will need prospective multicenter trials, standardized benchmarks and evidence of clinical and economic benefit.
rundown: The authors separate diagnostic accuracy from downstream effects on clinical workflow, patient outcomes and cost, and they note that the endpoint being detected differs across studies, ranging from acute coronary occlusion to functional ischemia.

They discuss translational barriers including limited prospective validation, regulatory hurdles and uncertain cost-effectiveness, alongside newer directions such as foundation models and multimodal fusion.

Most of the evidence comes from retrospective, frequently single-center studies of diagnostic performance. Few studies have measured workflow effects, and fewer still have measured patient outcomes or cost.
sources:
- peer_reviewed | Sensors | https://doi.org/10.3390/s26206503 | 2026-10-14
prev: 0000000000000000000000000000000000000000000000000000000000000000
sha256
9d80da042b458cd1b5bde1d430084274fc8a0ae22219d999979bd535ca4b4b43
previous
0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-1434 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.